4.5 Article

Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation

Journal

EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 19, Issue 6, Pages 647-654

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2010.256

Keywords

ZMPSTE24; mandibuloacral dysplasia; congenital myopathy; prelamin A; secondary laminopathies

Funding

  1. Institut National de la Sante et de la Recherche Medicale
  2. Universite Pierre et Marie Curie Paris [06]
  3. Universite de la Mediterranee
  4. Centre National de la Recherche Scientifique
  5. Association Francaise contre les Myopathies [11057, 11034]
  6. European Union [018690, 223576]

Ask authors/readers for more resources

Mutation in ZMPSTE24 gene, encoding a major metalloprotease, leads to defective prelamin A processing and causes type B mandibuloacral dysplasia, as well as the lethal neonatal restrictive dermopathy syndrome. Phenotype severity is correlated with the residual enzyme activity of ZMPSTE24 and accumulation of prelamin A. We had previously demonstrated that a complete loss of function in ZMPSTE24 was lethal in the neonatal period, whereas compound heterozygous mutations including one PTC and one missense mutation were associated with type B mandibuloacral dysplasia. In this study, we report a 30-year longitudinal clinical survey of a patient harboring a novel severe and complex phenotype, combining an early-onset progeroid syndrome and a congenital myopathy with fiber-type disproportion. A unique homozygous missense ZMPSTE24 mutation (c.281T4C>p. Leu94Pro) was identified and predicted to produce two possible ZMPSTE24 conformations, leading to a partial loss of function. Western blot analysis revealed a major reduction of ZMPSTE24, together with the presence of unprocessed prelamin A and decreased levels of lamin A, in the patient's primary skin fibroblasts. These cells exhibited significant reductions in lifespan associated with major abnormalities of the nuclear shape and structure. This is the first report of MAD presenting with confirmed myopathic abnormalities associated with ZMPSTE24 defects, extending the clinical spectrum of ZMPSTE24 gene mutations. Moreover, our results suggest that defective prelamin A processing affects muscle regeneration and development, thus providing new insights into the disease mechanism of prelamin A-defective associated syndromes in general. European Journal of Human Genetics (2011) 19, 647-654; doi:10.1038/ejhg.2010.256; published online 26 January 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available